Fresenius Medical Care AG (LON:0H9X)

Market Cap	10.76B
Revenue (ttm)	16.73B
Net Income (ttm)	562.68M
Shares Out	n/a
EPS (ttm)	1.91
PE Ratio	19.13
Forward PE	10.80
Dividend	1.21 (2.88%)
Ex-Dividend Date	May 23, 2025

Volume	64,283
Average Volume	132,535
Open	42.89
Previous Close	42.79
Day's Range	42.50 - 43.03
52-Week Range	35.03 - 54.00
Beta	0.88
RSI	47.84
Earnings Date	Nov 4, 2025

About Fresenius Medical Care AG

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospital...

• Industry: Miscellaneous Health And Allied Services, Not Elsewhere Classified
• Founded: 1996
• Employees: 111,513
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0H9X

Financial Performance

In 2024, Fresenius Medical Care AG's revenue was 19.34 billion, a decrease of -0.61% compared to the previous year's 19.45 billion. Earnings were 537.91 million, an increase of 7.80%.

Financial numbers in EUR